JP2024038140A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024038140A5 JP2024038140A5 JP2023220226A JP2023220226A JP2024038140A5 JP 2024038140 A5 JP2024038140 A5 JP 2024038140A5 JP 2023220226 A JP2023220226 A JP 2023220226A JP 2023220226 A JP2023220226 A JP 2023220226A JP 2024038140 A5 JP2024038140 A5 JP 2024038140A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- arg
- group
- thr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18158034 | 2018-02-22 | ||
| EP18158034.1 | 2018-02-22 | ||
| PCT/EP2019/054400 WO2019162423A1 (en) | 2018-02-22 | 2019-02-22 | Variants of porcine trypsin |
| JP2020544428A JP7432516B2 (ja) | 2018-02-22 | 2019-02-22 | ブタトリプシンの変異体 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544428A Division JP7432516B2 (ja) | 2018-02-22 | 2019-02-22 | ブタトリプシンの変異体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024038140A JP2024038140A (ja) | 2024-03-19 |
| JP2024038140A5 true JP2024038140A5 (enExample) | 2024-06-28 |
| JP7699196B2 JP7699196B2 (ja) | 2025-06-26 |
Family
ID=61274085
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544428A Active JP7432516B2 (ja) | 2018-02-22 | 2019-02-22 | ブタトリプシンの変異体 |
| JP2023220226A Active JP7699196B2 (ja) | 2018-02-22 | 2023-12-27 | ブタトリプシンの変異体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544428A Active JP7432516B2 (ja) | 2018-02-22 | 2019-02-22 | ブタトリプシンの変異体 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11518988B2 (enExample) |
| EP (1) | EP3755794A1 (enExample) |
| JP (2) | JP7432516B2 (enExample) |
| KR (1) | KR102863070B1 (enExample) |
| CN (1) | CN111989401A (enExample) |
| AU (1) | AU2019225972B2 (enExample) |
| BR (1) | BR112020016954A2 (enExample) |
| CA (1) | CA3091943A1 (enExample) |
| IL (1) | IL276799A (enExample) |
| MX (1) | MX2020008766A (enExample) |
| MY (1) | MY200951A (enExample) |
| SG (1) | SG11202008026WA (enExample) |
| WO (1) | WO2019162423A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019162423A1 (en) | 2018-02-22 | 2019-08-29 | Sanofi-Aventis Deutschland Gmbh | Variants of porcine trypsin |
| CN111676211B (zh) * | 2020-05-15 | 2022-07-19 | 天津科技大学 | 一种抗自切和高比活力胰蛋白酶突变体 |
| CN119552847B (zh) * | 2025-01-21 | 2025-04-11 | 四川大学 | 链霉菌胰蛋白酶自剪切位点突变体及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010022452A (ko) * | 1997-07-31 | 2001-03-15 | 추후제출 | 플라비바이러스 감염에 대한 재조합 다이머형 엔벨롭 백신 |
| US7622113B2 (en) * | 2003-12-08 | 2009-11-24 | The United States Of America As Represented By The Department Of Health And Human Services | Monoclonal antibodies that bind or neutralize dengue virus |
| ATE517919T1 (de) * | 2005-09-14 | 2011-08-15 | Sanofi Aventis Deutschland | Spaltung von insulinvorstufen durch eine trypsinvariante |
| BR112013009649A2 (pt) * | 2010-10-29 | 2016-07-12 | Merck Sharp & Dohme | composição imunogênica, métodos para provocar uma resposta imune protetora em um paciente humano e para fornecer proteção imune em seres humanos contra doença, e, uso de uma composição |
| US9267114B2 (en) * | 2012-11-07 | 2016-02-23 | Southern Research Institute | Flavivirus envelope protein mutations affecting virion disassembly |
| WO2019162423A1 (en) * | 2018-02-22 | 2019-08-29 | Sanofi-Aventis Deutschland Gmbh | Variants of porcine trypsin |
-
2019
- 2019-02-22 WO PCT/EP2019/054400 patent/WO2019162423A1/en not_active Ceased
- 2019-02-22 BR BR112020016954-4A patent/BR112020016954A2/pt unknown
- 2019-02-22 SG SG11202008026WA patent/SG11202008026WA/en unknown
- 2019-02-22 AU AU2019225972A patent/AU2019225972B2/en active Active
- 2019-02-22 JP JP2020544428A patent/JP7432516B2/ja active Active
- 2019-02-22 US US16/971,491 patent/US11518988B2/en active Active
- 2019-02-22 KR KR1020207026991A patent/KR102863070B1/ko active Active
- 2019-02-22 CN CN201980026139.4A patent/CN111989401A/zh active Pending
- 2019-02-22 MX MX2020008766A patent/MX2020008766A/es unknown
- 2019-02-22 MY MYPI2020004295A patent/MY200951A/en unknown
- 2019-02-22 CA CA3091943A patent/CA3091943A1/en active Pending
- 2019-02-22 EP EP19705541.1A patent/EP3755794A1/en active Pending
-
2020
- 2020-08-19 IL IL276799A patent/IL276799A/en unknown
-
2022
- 2022-10-27 US US18/050,446 patent/US11952602B2/en active Active
-
2023
- 2023-12-27 JP JP2023220226A patent/JP7699196B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2011020319A1 (zh) | 调节血糖血脂的融合蛋白及其制备方法和应用 | |
| KR890003802A (ko) | 재조합 dna 기술에 의해 제조된 소의 췌장 트립신 억제제, 그 제조 방법, 발현 벡터 및 재조합 숙주 및 그의 제약적 용도 | |
| CA2489227A1 (en) | Hla-a24-restricted cancer antigen peptides | |
| JP7699196B2 (ja) | ブタトリプシンの変異体 | |
| JP7677901B2 (ja) | グルカゴン様ペプチド－１（ｇｌｐ－１）受容体アゴニストとその類似体の製造プロセス | |
| US20180251511A1 (en) | Process for the preparation of liraglutide | |
| JP2020517260A5 (enExample) | ||
| CA3030534A1 (en) | Fusion proteins with extended serum half life | |
| JP2008515437A (ja) | 血管活性腸管ポリペプチド医薬品 | |
| WO2025040192A1 (zh) | 新型胰岛素衍生物及其用途 | |
| JPH11505706A (ja) | 肥満症遺伝子産物 | |
| CN111718417A (zh) | 含有荧光蛋白片段的融合蛋白及其用途 | |
| Tomisawa et al. | Efficient production of a correctly folded mouse α-defensin, cryptdin-4, by refolding during inclusion body solubilization | |
| JP2653061B2 (ja) | 新規ポリペプチドおよびその製造法 | |
| CN1350584A (zh) | 从新的融合蛋白制造重组胰岛素的方法 | |
| EP0381433B1 (en) | A method for the production of glucagon | |
| EP1908778A1 (en) | Exendin 4 polypeptide fragments and use thereof | |
| Mahmoud et al. | Production of a biologically active novel goldfish growth hormone in Escherichia coli | |
| Chunxiao et al. | Study on preparation and activity of a novel recombinant human parathyroid hormone (1–34) analog with N-terminal Pro–Pro extension | |
| Tu et al. | Expression of CTB-10× rolGLP-1 in E. coli and its therapeutic effect on type 2 diabetes | |
| CN113527506A (zh) | 融合蛋白及其应用 | |
| CN1052332A (zh) | 制备脱(64，65)胰岛素原的方法 | |
| CN114651063A (zh) | 用于表达重组治疗性肽的n-末端延伸序列 | |
| KR100407792B1 (ko) | 인간 글루카곤 유사펩타이드를 융합파트너로 이용한재조합 단백질의 제조방법 | |
| LT6164B (lt) | Sulieti interferono-alfa 5 baltymai su kitu citokinu ir jų gamybos būdas |